SciSparc Stock Price, News & Analysis

SPRCY OTC

Company Description

SciSparc (OTC: SPRCY) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

This page provides a comprehensive overview of SPRCY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

4.0M

Shares outstanding

Latest News

View All

March 10, 2022

—

SciSparc Launches New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases

February 22, 2022

—

SciSparc to Present at Aegis Virtual Conference

conferences

January 27, 2022

—

SciSparc Presents New Leadership Lineup

January 18, 2022

—

SciSparc Advances Its Phase IIb Clinical Trial in Patients with Tourette Syndrome with its Proprietary Drug Candidate SCI-110

clinical trial

January 11, 2022

—

SciSparc Exploring Psychedelics as Possible Avenue to Expand Its IP Portfolio

January 6, 2022

—

SciSparc Announces Recruitment of First Patient for its Phase IIa Clinical Trial in Alzheimer's Disease

clinical trial

SciSparc has 10 recent news articles. Key topics include conferences, clinical trial. View all SPRCY news →

SEC Filings

View All

No SEC filings available for SPRCY.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

SPRCY Company Profile & Sector Positioning

SciSparc (SPRCY) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.